Glenmark
The status, timeline and source of this project. A free account opens every field.
Source: International Finance Corporation (IFC)
Founded in 1977, Glenmark Pharmaceuticals Limited (“Glenmark” or “the company”) is a leading Indian manufacturer of generic pharmaceuticals. The company engages in the development, manufacturing, and marketing of pharmaceutical products and active pharmaceutical ingredients (APIs) in India and internationally, and offers products in a range of therapies including respiratory, dermatology, cardiova
- Status
- Closed
- Sector
- Water Supply and Storage, Commercial, Chemical (Industrial), Manufacturing (Industrial), Warehouse, Waste Processing and Treatment, Residential, Government, Hospital
- Location
- India
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about Glenmark
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | completed |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Founded in 1977, Glenmark Pharmaceuticals Limited (“Glenmark” or “the company”) is a leading Indian manufacturer of generic pharmaceuticals. The company engages in the development, manufacturing, and marketing of pharmaceutical products and active pharmaceutical ingredients (APIs) in India and internationally, and offers products in a range of therapies including respiratory, dermatology, cardiovascular and oncology.The company has a global presence in more than 60 countries and 17 manufacturing facilities across India, United States (US), Argentina and Czech Republic. Of the 13 manufacturing facilities in India, five are API manufacturing facilities and located at Mohol, Kurkumbh and Aurangabad (in Mahrashtra), and Ankleshwar and Dahej (in Gujarat); the remaining are formulation facilities in Baddi and Nalagarh (in Himachal Pradesh), Nashik and Aurangabad (in Maharashtra), Indore (Madhya Pradesh), Sikkim and Goa. In addition, all overseas facilities are formulation facilities.The company is also involved in the discovery of new chemical entities and new biological entities and has five Research and Development (R&D) centers across India and Switzerland.The proposed investment is upto $75 million through quasi-equity instruments to be used for; (a) expanding manufacturing capacity (primarily in India); (b) building R&D capacity for new products (including in India); and (c) reduce debt so that internal accruals can be deployed to R&D (“the project”). |
Original sector | G-FA - Pharmaceuticals and Medicine |
Location
Country | India |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Water Supply and Storage, Commercial, Chemical (Industrial), Manufacturing (Industrial), Warehouse, Waste Processing and Treatment, Residential, Government, Hospital |
Article published date | 2025-09-10 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Water Supply and Storage projects in India
- Kiru Hydroelectric Project Jammu and Kashmir India
- Pinnapuram Integrated Renewable Energy Project India
- Chuzachen Hydroelectric Power Project Sikkim
- Mahan I Power Project Madhya Pradesh
- Rampur Hydro Electric Power Project Himachal Pradesh
- UriII Hydroelectric Project Jammu and Kashmir
- Kakrapar Atomic Power Station Expansion
- Nathpa Jhakri India Hydroelectric Power Plant
